tiprankstipranks
AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
PremiumThe FlyAbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
25d ago
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
PremiumPress Releases
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
25d ago
AbbVie to acquire Landos Biopharma got $20.42 per share in cash
PremiumThe Fly
AbbVie to acquire Landos Biopharma got $20.42 per share in cash
25d ago
Landos Biopharma, Inc. (LABP) Q4 Earnings Cheat Sheet
PremiumPre-EarningsLandos Biopharma, Inc. (LABP) Q4 Earnings Cheat Sheet
1M ago
Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation
PremiumPress Releases
Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation
3M ago
Landos Biopharma publishes results of NX-13 Phase 1b study in UC
PremiumThe Fly
Landos Biopharma publishes results of NX-13 Phase 1b study in UC
5M ago
Landos Biopharma Announces Strategic Research Collaboration with KU Leuven and University Hospitals Leuven to Further Characterize the Effects of NX-13 on Epithelial Cells
PremiumPress ReleasesLandos Biopharma Announces Strategic Research Collaboration with KU Leuven and University Hospitals Leuven to Further Characterize the Effects of NX-13 on Epithelial Cells
7M ago
Landos Biopharma announces strategic research collaboration with KU Leuven
PremiumThe Fly
Landos Biopharma announces strategic research collaboration with KU Leuven
7M ago
Landos Biopharma reports Q2 EPS (63c) vs ($2.80) last year
PremiumThe Fly
Landos Biopharma reports Q2 EPS (63c) vs ($2.80) last year
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100